Category Archives: healthcare

Healthcare Systems in Europe "Failing Patients"

By Reflector, Brussels correspondent. Any complacency that the world of healthcare might be feeling about advances in the ability to treat patients suffered a head-on assault in Dublin, Ireland, last week, at a conference organized under the auspices of the Irish Presidency of the European Union and featuring a galaxy of Irish and European stars from [...]
Also posted in Europe, Guest Blog, Op-Ed | Tagged , , , , , , | 1 Comment

Are US and Canadian Rx Policies Converging?

by Tom Norton As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program.  To say that this is a critical concern for the future [...]
Also posted in Global, Guest Blog, Legal, Market Access, Strategy | Tagged , , , , , , | Leave a comment

Congress, FDA Should Consider Tech Solutions for Safer Compounding

By Niels Erik Hansen Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic reminder of the risk of errors inherent in manual pharmacy medication compounding. Unsanitary conditions at the Massachusetts compounding pharmacy that made the injections resulted in fungal contamination of the drugs. The resulting outbreak sickened nearly 700 people in [...]
Also posted in Guest Blog, Manufacturing, Regulatory, Safety, Technology, compliance | Tagged , , , , | Leave a comment

Sequestration: How Big a Hit for FDA, Research and Pharma?

The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality [...]
Also posted in FDA, Legal, R&D, leadership | Tagged , , , , , , , | Leave a comment

Changing the DNA of Pharma Patient Adherence Programs

by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors.  Pharma is also experiencing epigenetic change.  Human genes are formed from DNA, which are instructions much like a blueprint.  Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Also posted in E-Media, Marketing, Patient Communication, compliance, patient compliance, patient education | Tagged , , , , , , | 3 Comments